We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Sewage Treatment Plants Could Exacerbate Antibiotic Resistance Problem

By HospiMedica International staff writers
Posted on 20 Dec 2011
Water discharged into lakes and rivers from municipal sewage treatment plants may contain significant concentrations of specific genes that make bacteria antibiotic-resistant, claims a new study. More...


Researchers at the University of Minnesota (Minneapolis, USA) studied the impact of tertiary-treated municipal wastewater on the quantity of several antibiotic resistance determinants in Lake Superior in the Duluth (MN, USA) area. The researchers collecting surface water and sediment samples from 13 locations in Duluth-Superior Harbor, the St. Louis River, and Lake Superior. Quantitative Polymerase Chain Reaction (qPCR) was used to target three different genes encoding resistance to tetracycline (tet(A), tet(X), and tet(W)), the gene encoding the integrase of class 1 integrons (intI1), total bacterial abundance (16S rRNA genes), and total and human fecal contamination levels (16S rRNA genes specific to the genus Bacteroides).

The results showed that the quantities of tet(A), tet(X), tet(W), intI1, total Bacteroides, and human-specific Bacteroides were typically 20-fold higher in the tertiary-treated wastewater than in nearby surface water samples. In contrast, the quantities of these genes in the St. Louis River and Lake Superior were typically below detection. Analysis of sequences of tet(W) gene fragments from four different samples collected throughout the study site supported the conclusion that tertiary-treated municipal wastewater is a point source of resistance genes into Duluth-Superior Harbor. The study was published in the November 15, 2011, issue of Environmental Science & Technology.

“Current wastewater treatment removes a very large fraction of the antibiotic resistance genes,” said lead author associate professor Timothy LaPara, PhD, of the department of civil engineering. “But this study shows that wastewater treatment operations need to be carefully considered and more fully studied as an important factor in the global ecology of antibiotic resistance.”

The ever-increasing presence of antibiotic-resistant bacteria has raised substantial concern on the future effectiveness of antibiotics. While antibiotic use in agriculture has been heavily scrutinized, the roles of sewage and municipal wastewater treatment have received little attention as a reservoir of resistance. Antibiotic-resistant bacteria develop in the gastrointestinal (GI) tracts of people taking antibiotics; these bacteria are then shed during defecation. Antibiotic resistance can then be transferred between organisms via lateral gene transfer, becoming part of the ongoing major health problem of antibiotic resistant pathogens.

Related Links:

University of Minnesota



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.